Mutual of America Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-56,650
Closed -$9.36M 1680
2021
Q2
$9.36M Sell
56,650
-1,682
-3% -$281K 0.09% 237
2021
Q1
$8.94M Sell
58,332
-1,551
-3% -$211K 0.09% 244
2020
Q4
$7.51M Buy
59,883
+134
+0.2% +$15K 0.09% 280
2020
Q3
$6.06M Sell
59,749
-99
-0.2% -$10.1K 0.08% 286
2020
Q2
$5.82M Buy
59,848
+1,006
+2% +$93.6K 0.08% 282
2020
Q1
$4.89M Buy
58,842
+1,914
+3% +$187K 0.08% 292
2019
Q4
$6.33M Buy
56,928
+1,071
+2% +$110K 0.08% 325
2019
Q3
$5.54M Buy
55,857
+3,786
+7% +$376K 0.08% 346
2019
Q2
$5.16M Sell
52,071
-2,189
-4% -$209K 0.07% 386
2019
Q1
$5.98M Sell
54,260
-115
-0.2% -$12K 0.09% 296
2018
Q4
$5M Buy
54,375
+2,549
+5% +$258K 0.08% 325
2018
Q3
$5.71M Buy
51,826
+8,327
+19% +$867K 0.08% 337
2018
Q2
$4.06M Buy
43,499
+73
+0.2% +$6.29K 0.06% 510
2018
Q1
$3.6M Buy
43,426
+12,600
+41% +$1.12M 0.06% 557
2017
Q4
$2.81M Buy
+30,826
New +$2.56M 0.04% 702

Other funds holding PRAH

Mutual of America Capital Management's PRAH Position: Q3 2021 in Review

Mutual of America Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 56,650 shares — an estimated $9.36M sold.

Mutual of America Capital Management first reported a position in PRAH in Q4 2017 and held it in 15 quarters. The position peaked at $9.36M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Mutual of America Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Mutual of America Capital Management sold 56,650 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $9.36M.
  • Mutual of America Capital Management first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 15 quarters.
  • Mutual of America Capital Management's PRA Health Sciences, Inc. position peaked at $9.36M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Mutual of America Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.